MedTrace Logo

The Registration Program of BRCA1/2 Gene

NCT02593435 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 8000

Last updated 2016-03-24

No results posted yet for this study

Summary

Purpose:

1. Screening of large samples is to search the gene mutation of the breast cancer susceptibility gene (BRCA1 and BRCA2) in Chinese high risk group.
2. To build the breast cancer BRCA1/2 mutation database of Chinese group.
3. To build the hazard model of breast cancer BRCA1/2 mutation of Chinese group.

Conditions

Interventions

GENETIC

NGS test

To record the characteristic QC parameters and evaluate the detection performance of Next-Generation Sequencing (NGS), including coverage depth and sequence similarity, then be used to evaluate the quality of base recognition and alignment. To know mutation characteristic spectrum of BRCA1/2.

Sponsors & Collaborators

  • Chinese Anti-Cancer Association

    lead OTHER

Principal Investigators

  • Ze-Fei Jiang, Doctor · 307 Hospital of PLA

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2016-06-30
Completion
2016-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02593435 on ClinicalTrials.gov